Who
Kurt J. Hilzinger
Director
Company insider
Files Form 4 as: Director, Humana; Director, Outlook Therapeutics; President & COO, Cencora.
In numbers
- Trades disclosed
- 170
- Buys
- 37
- Sells
- 1
- Bought
- $1.1M
- Sold
- $6.2M
- Companies
- 3
- Companies where not an officer
- 2
- First trade
- 3 Jan 2006
- Last trade
- 30 Sep 2026
- Last filed
- 2 Oct 2026
Companies traded
Activity over time
1 Nov 2024 – 1 Oct 2026
Buys above the line, sells below, each month.
Every trade
| Traded | Company | What | Amount | |
|---|---|---|---|---|
| 30 Sep 2026filed 2 Oct 2026 | HUM Humanaoption or derivative · Managed Care & Insurers | SEC FORM 4 Code A | $92K238 at $384.91 | filing |
| 30 Jun 2026filed 2 Jul 2026 | HUM Humanaoption or derivative · Managed Care & Insurers | SEC FORM 4 Code A | $91K233 at $392.32 | filing |
| 30 Jun 2026filed 2 Jul 2026 | HUM Humanaoption or derivative · Managed Care & Insurers | SEC FORM 4 Code A | $91K233 at $392.32 | filing |
| 26 May 2026filed 27 May 2026 | OTLK Outlook TherapeuticsBiotechnology | SEC FORM 4 Bought | $177K400,000 at $0.4413 | filing |
| 26 May 2026filed 27 May 2026 | OTLK Outlook TherapeuticsBiotechnology | SEC FORM 4 Bought | $176K400,000 at $0.44 | filing |
| 31 Mar 2026filed 2 Apr 2026 | HUM Humanaoption or derivative · Managed Care & Insurers | SEC FORM 4 Code A | $91K536 at $170.66 | filing |
| 31 Mar 2026filed 2 Apr 2026 | HUM Humanaoption or derivative · Managed Care & Insurers | SEC FORM 4 Code A | $91K536 at $170.66 | filing |
| 2 Jan 2026filed 5 Jan 2026 | HUM Humanaoption or derivative · Managed Care & Insurers | SEC FORM 4 Code A | —766 at $0.00 | filing |
| 2 Jan 2026filed 5 Jan 2026 | HUM Humanaoption or derivative · Managed Care & Insurers | SEC FORM 4 Code A | —766 at $0.00 | filing |
| 31 Dec 2025filed 5 Jan 2026 | HUM Humanaoption or derivative · Managed Care & Insurers | SEC FORM 4 Code A | $158K611 at $258.87 | filing |
| 31 Dec 2025filed 5 Jan 2026 | HUM Humanaoption or derivative · Managed Care & Insurers | SEC FORM 4 Code A | $92K357 at $258.87 | filing |
| 31 Dec 2025filed 5 Jan 2026 | HUM Humanaoption or derivative · Managed Care & Insurers | SEC FORM 4 Code A | $158K611 at $258.87 | filing |
| 31 Dec 2025filed 5 Jan 2026 | HUM Humanaoption or derivative · Managed Care & Insurers | SEC FORM 4 Code A | $92K357 at $258.87 | filing |
| 3 Oct 2025filed 3 Oct 2025 | OTLK Outlook Therapeuticsoption or derivative · Biotechnology | SEC FORM 4 Code A | —90,638 at $0.00 | filing |
| 1 Oct 2025filed 3 Oct 2025 | OTLK Outlook Therapeuticsoption or derivative · Biotechnology | SEC FORM 4 Code A | —286,734 at $0.00 | filing |
| 30 Sep 2025filed 2 Oct 2025 | HUM Humanaoption or derivative · Managed Care & Insurers | SEC FORM 4 Code A | $94K364 at $257.79 | filing |
| 30 Jun 2025filed 2 Jul 2025 | HUM Humanaoption or derivative · Managed Care & Insurers | SEC FORM 4 Code A | $97K399 at $242.82 | filing |
| 31 Mar 2025filed 2 Apr 2025 | HUM Humanaoption or derivative · Managed Care & Insurers | SEC FORM 4 Code A | $91K345 at $263.88 | filing |
| 2 Jan 2025filed 3 Jan 2025 | HUM Humanaoption or derivative · Managed Care & Insurers | SEC FORM 4 Code A | —783 at $0.00 | filing |
| 31 Dec 2024filed 3 Jan 2025 | HUM Humanaoption or derivative · Managed Care & Insurers | SEC FORM 4 Code A | $144K565 at $254.93 | filing |
News
Reviewing Aprea Therapeutics (NASDAQ:APRE) & Oncobiologics (NASDAQ:OTLK)OTLK · themarketsdaily.com · 20 Oct 2026
0 headlines in the last 90 days name Kurt J. Hilzinger; 1 article from the last 14 days about the 1 company they traded most, at most three about any one of them.